2021
DOI: 10.1007/s40005-021-00542-y
|View full text |Cite
|
Sign up to set email alerts
|

Statistical design of experiment-based formulation development and optimization of 3D printed oral controlled release drug delivery with multi target product profile

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
5
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 10 publications
(6 citation statements)
references
References 96 publications
0
5
0
Order By: Relevance
“…Filaments were kept in sealed plastic bags and stored in a desiccator at room temperature until further characterizations. The 3D-printed tablets were successfully produced by using a commercial-material-extrusion 3D printer, MakerBot Replicator 2× (MakerBot Inc., Brooklyn, NY 11201, USA), with a dual nozzle of 0.4 mm diameter [ 25 , 26 ]. The printing temperature was set at 200 °C for all formulations.…”
Section: Methodsmentioning
confidence: 99%
See 2 more Smart Citations
“…Filaments were kept in sealed plastic bags and stored in a desiccator at room temperature until further characterizations. The 3D-printed tablets were successfully produced by using a commercial-material-extrusion 3D printer, MakerBot Replicator 2× (MakerBot Inc., Brooklyn, NY 11201, USA), with a dual nozzle of 0.4 mm diameter [ 25 , 26 ]. The printing temperature was set at 200 °C for all formulations.…”
Section: Methodsmentioning
confidence: 99%
“…Thermal analysis was used to understand the polymer composites, but the mechanical factor was neglected. A texture analyzer was applied, and the breaking stress and breaking distance of the successful printed filaments were studied to determine the optimal extrusion range [ 24 , 25 , 26 ]; however, the mechanical measurement still does not mimic the thermal factor in the extrusion process [ 18 ].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…However, even quality by design (QbD)-based approach studies at the laboratory scale are not enough, as is the case with the pilot or commercial scale. The lack of the fundamental understanding of the theory of particle formation in SFEE following the lack of scientific analysis of experimental data for controlling fine particle formation from lab scale to scale-up can be compensated by studies using QbD-based approaches [93][94][95][96][97][98]. Thus, to achieve successful GMP scale-up and commercial mass production technology, it is essential to establish validated and robust technology through a scientific and statistical strategy based on the QbD approach [99,100].…”
Section: Expert Opinions and Perspectivesmentioning
confidence: 99%
“…The fastest release was observed for formulations containing crospovidone [22]. The impact of disintegrants has also been analyzed by several other research groups [23][24][25]. Hussain et al analyzed HPC SL-based formulations containing captopril and disintegrants.…”
Section: Introductionmentioning
confidence: 99%